The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9000047 B1

PDF
Full Text
Expired
Date of Patent:
Apr. 07, 2015

Filed:

May. 24, 2010
Applicants:

Pilar Navarro Medrano, Alcobendas, ES;

Elisabet Gregori Puigjane, Alcobendas, ES;

Marisol Montolio Del Olmo, Alcobendas, ES;

Ana Jimenez Redondo, Alcobendas, ES;

Jordi Mestres Lopez, Alcobendas, ES;

Inventors:

Pilar Navarro Medrano, Alcobendas, ES;

Elisabet Gregori Puigjane, Alcobendas, ES;

Marisol Montolio Del Olmo, Alcobendas, ES;

Ana Jimenez Redondo, Alcobendas, ES;

Jordi Mestres Lopez, Alcobendas, ES;

Assignee:

Farmalider, S.A., Madrid, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/13 (2006.01); A01N 33/02 (2006.01); A61K 31/137 (2006.01);
U.S. Cl.
CPC ...
A61K 31/13 (2013.01); A61K 31/137 (2013.01);
Abstract

The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the β-amyloid peptide.


Find Patent Forward Citations

Navarro Medrano, Pilar. (2015). Compound inhibiting activation of the enzyme erk 1/2 to be used in the treatment of neurodegenerative illnesses (U.S. Patent No. 9000047). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9000047

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…